Abbreviations: ANOVA, analysis of variance; ATP, adenosine triphosphate; CHR, effect of chronic nitrate supplementation alone assessed; CHR + ACU, combined effect of chronic and acute nitrate supplementation assessed; GET, gas exchange threshold; NO, nitric oxide; NO 2 -, nitrite; NO 3 -, nitrate; O 2 , oxygen; PLA, placebo; Rpm, revolutions per minute; O 2 , oxygen uptake; O 2peak , peak oxygen uptake; W, watts; ∆, change.
Introduction
Dietary nitrate (NO 3 - ) has been reported to influence several physiological processes via its reduction to nitrite (NO 2 -), and subsequently to the physiological signaling molecule nitric oxide (NO) [1] [2] [3] . Indeed, acute ingestion (1-3 h) and chronic supplementation (3-15 days) with dietary NO 3 -has been found to increase plasma NO 2 -concentration [NO 2 - ], and, in some studies, to reduce the oxygen (O 2 ) cost of submaximal exercise [4] [5] [6] and improve exercise tolerance [5] [6] [7] in healthy, young adults (see [8] for review). However, the influence of different supplementation strategies on the physiological effects of NO 3 -ingestion is still not fully understood.
Whilst a reduction in the O 2 cost of submaximal exercise has been reported 1-3 h post consumption of 5.2-16.8 mmol NO 3 - in some studies [6, 9, 10] , reports on the effect of ingesting a lower dose (i.e. 4.2 mmol NO 3 -or below) are ambiguous [6, 11] . It has been suggested that chronic supplementation with NO 3 -may represent a more effective supplementation strategy [8, 10] . Indeed, 3-7 days of NO 3 -supplementation has been reported to improve mitochondrial efficiency [12] and contractile function [13] by altering the expression of mitochondrial [12] and contractile [13] proteins in skeletal muscle. These structural adaptations are likely to be responsible, in part, for the reduction in submaximal O 2 uptake ( O 2 ) after chronic NO 3 -supplementation, but would unlikely be manifest within [1] [2] [3] h after the ingestion of a single NO 3 -bolus. Given this potential benefit of a chronic NO 3 - supplementation period, it may be reasoned that a significant and consistent reduction in submaximal exercise O 2 could be achieved with a low dose of NO 3 -if consumed daily for an extended period of time. However, the effect of chronic supplementation with a low dose of NO any effects observed with CHR + ACU would still be present, albeit to a lesser extent, with CHR.
METHODS

Subjects
Thirty-four healthy, recreationally-active subjects (19 male, mean ± SD age = 21 ± 3 yr, stature = 1.74 ± 0.09 m, body mass = 73.5 ± 14.1 kg) volunteered to participate, gave written informed consent, and completed this study that was approved by the Institutional Research Ethics Committee. All subjects were nonsmokers and none were taking any nutritional supplements in the four months preceding the start of the study. Throughout the experimentation, subjects were asked to adhere to their normal exercise routine and diet.
However, subjects were instructed to avoid foods rich in NO 3 -(such as green leafy vegetables and beetroot) and asked to record their diet and exercise in the 48 h preceding the first laboratory visit and to repeat this prior to all subsequent visits. Subjects were instructed to arrive at the laboratory in a rested and fully hydrated state, at least 2 h postprandial, and to avoid strenuous exercise in the 24 h preceding each testing session. Each subject was also asked to avoid caffeine and alcohol 6 and 24 h before each test, respectively. In addition, subjects were asked to abstain from using antibacterial mouthwash and chewing gum for the duration of the study since this inhibits the reduction of NO 3 -to NO 2 -in the oral cavity [14] .
All laboratory visits were scheduled at the same time of day (± 1 h) for each subject. rpm below the chosen pedal rate, despite strong verbal encouragement. The power output achieved at the point of exhaustion was recorded as the peak power output (PPO). Pulmonary gas exchange was continuously collected breath-by-breath during the incremental tests and averaged over consecutive 10-s periods. The O 2peak was calculated as the highest 30-s mean value attained before the subject's volitional exhaustion. The GET was determined as described previously [15, 16] . The work rate that would require 80 % of the GET (moderate exercise) was then calculated, with account taken of the mean response time for O 2 during ramp exercise (i.e. two-thirds of the ramp rate was deducted from the work rate at GET; [17] data from the two moderate-intensity bouts were time aligned and averaged to improve signal-to-noise ratio [18] . The O 2 cost of moderate-intensity exercise was then calculated. All measurements made during this visit were used as pre-treatment baseline data.
Pre-treatment tests
Supplementation procedures
After these pre-treatment visits, subjects were assigned in a group-matched fashion for is attained 2 h post beetroot juice consumption [6] , it could not be assumed that this time-topeak is consistent after consumption of other NO 3 -containing supplements because the kinetics of plasma [NO 2 -] may be altered by the form in which the NO 3 -is administered [19] .
We therefore undertook a pilot study which indicated that peak plasma [NO 2 -] occurred at 2 h post consumption of the dry beetroot extract (unpublished observation). On nonexperimental days, each subject was instructed to consume their allocated supplement at their test time from visit 2 (± 10 min), such that the subject would consume one dose of supplement every 24 h.
To assess the effect of chronic NO 3 -supplementation on the O 2 cost of submaximal exercise with and without the acute consumption of NO 3 -2 h prior to exercise, a randomised counterbalanced design was adopted from day 28 of supplementation for subjects in the 3 mmol and 6 mmol groups ( Therefore, all subjects were assessed for the CHR + ACU and CHR effects of NO 3 - supplementation. In all cases, subjects in the 3 mmol and 6 mmol groups consumed 3 mmol NO 3 -or 6 mmol NO 3 -, respectively, per day. Subjects in the PLA group were instructed to continue their normal supplementation routine and consume one dose of PLA 2 h prior to arrival at the laboratory on both day 28 and 30 of supplementation.
Subjects in the 3 mmol and 6 mmol groups were deliberately misinformed that the effects of two different NO 3 -supplements on the physiological responses of exercise would be tested after different supplementation periods. Subjects in the PLA group were informed that the effect of a NO 3 -supplement would be tested over different supplementation periods. All subjects were asked to not comment on the taste or appearance of the supplements to the study investigators. Follow up verbal interviews after completion of the study confirmed that subjects were unaware of the actual research hypothesis.
Measurements and data analysis
During all exercise tests, pulmonary gas exchange and ventilation were measured breath-bybreath, with subjects wearing a nose clip and breathing through a low dead space, lowresistance mouthpiece and impeller turbine assembly (Jaeger Triple V, Hoechberg, Germany). The inspired and expired gas volume and gas concentration signals were continuously sampled at 100 Hz, the latter using paramagnetic (O 2 ) and infrared (CO 2 )
analyzers (Jaeger Oxycon Pro, Hoechberg, Germany) via a capillary line connected to the mouthpiece. The gas analyzers were calibrated before each test with gases of known concentration, and the turbine volume transducer was calibrated with a 3-liter syringe (Hans Rudolph, Kansas City, MO). Pulmonary gas exchange and ventilation were calculated and displayed breath-by-breath.
The breath-by-breath gas exchange data collected during the two identical, moderateintensity step tests performed at pre-treatment baseline on visit 2 and on days 1, 7, 28 and 30 of supplementation, were averaged over 10-s periods, and time aligned to the start of exercise and ensemble-averaged. The end-exercise O 2 was defined as the mean value measured over the final 60 s of exercise.
Venous blood samples were drawn into lithium-heparin vacutainers (7.5 ml Monovette lithium heparin; Sarstedt, Leicester, UK 
Statistical analysis
A mixed-model ANOVA was used to assess differences in change from pre-treatment baseline, in all variables across treatment (PLA, 3 mmol NO 3 -and 6 mmol NO 3 -) and time (2 h and 7 d, and the CHR + ACU visit on day 28 or 30 of supplementation). Differences over time within each group were analyzed by a single factor repeated-measures ANOVA. Before these analyses, all data collected on days 28 and 30 of supplementation in the PLA group were averaged together to form one data point at days 28 and 30 of supplementation. The effect of CHR on all variables in 3 mmol and 6 mmol was analyzed separately using a single factor repeated measures (pre-treatment baseline, CHR and CHR + ACU) ANOVA. In all cases, significant effects were further explored using simple contrasts. All data analyses were performed using the SPSS (version 22; SPSS, Chicago, IL) statistical package, with statistical significance accepted at P<0.05. Results are presented as mean ± SD unless stated otherwise.
RESULTS
Self-reported compliance to the supplementation regime was 100 % in all treatment groups.
Subjects reported that their diet and exercise habits prior to each experimental test were consistent. 
Plasma [NO
2 h, 7 d and 28-30 day (CHR + ACU)
At pre-treatment baseline, plasma [NO ] from pre-treatment baseline was not significantly different between the three sampling time points within any treatment group (all P > 0.05).
Comparison between chronic and chronic + acute supplementation
The change in plasma [ ] had returned to pre-treatment baseline on the CHR visit in both the 3 mmol and 6 mmol groups (P > 0.05; Fig. 3B) 
Moderate-Intensity Exercise
At pre-treatment baseline, the O 2 measured over the final 60-s of moderate intensity exercise was not significantly different between treatment groups (PLA: 1.46 ± 0.32 L·min -1 ; 3 mmol:
1.44 ± 0.23 L·min -1 ; 6 mmol: 1.44 ± 0.30 L·min -1 : P > 0.05).
2 h, 7 d and 28-30 day (CHR + ACU)
The change in end-exercise O 2 from pre-treatment baseline at 2 h, 7 d and on the CHR + ACU visit after 28-30 d is shown in Fig. 4A . In the 3 mmol and PLA groups, end-exercise O 2 was not significantly different from pre-treatment baseline at any time point (all P > 0.05; 
Comparison between chronic and chronic + acute supplementation
In the 3 mmol group, end-exercise O 2 was not different from pre-treatment baseline at 28-30 d on either the CHR or CHR + ACU visits (P > 0.05). In the 6 mmol group, end-exercise O 2 was significantly lower than pre-treatment baseline at 28-30 days on the CHR visit (by ~3.5%; 0.05 ± 0.06 L·min -1 ; P < 0.05; Fig. 4B ). This reduction in end-exercise O 2 was not significantly different from that observed on the CHR + ACU visit (P > 0.05; Fig. 4B ).
DISCUSSION
The principal novel finding of the present study was that neither 7 days nor ~4 weeks of [4, 5, 9, 12, 24] . Therefore, these results indicate that the daily ingestion of 6 mmol NO 3 -reduces the O 2 cost of submaximal exercise after short duration (7 day) supplementation, and that this effect is maintained over ~4 weeks of continued supplementation with no evidence of a reduced sensitivity to supplementation.
The lowering of submaximal exercise O 2 may be a result of improved mitochondrial efficiency [12,25, cf. 26] and/or a reduction in the ATP cost of skeletal muscle force production [27] . Alterations in the expression, and therefore content, of mitochondrial [12] and contractile proteins [13] have been proposed as the mechanistic bases for these effects.
However, alterations in protein expression are unlikely to occur within 1-3 h of acute NO 3 -ingestion, and can therefore only contribute to a reduction in submaximal exercise O 2 after a period of chronic NO 3 -supplementation. Instead, a reduction in O 2 following acute NO 3 -ingestion may be related to an acute and reversible change in protein function through posttranslational protein modifications [28] . Given the potential for the protein expression changes to occur after chronic supplementation but not acute ingestion, we hypothesized that the prolonged exposure to elevated concentrations of NO 2 -provided by a chronic supplementation regime may reduce the dose of NO 3 -required to lower submaximal exercise O 2. In contrast to this hypothesis we found that extending the duration of supplementation on a low dose of NO 3 -to ~4 weeks did not result in a reduction in submaximal exercise O 2 .
This observation implies that these structural modifications are not only dependent on the duration of exposure but also the magnitude of the exposure. The influence of different NO 3 -doses and durations of supplementation on structural modifications to skeletal muscle warrants further investigation.
The effect of chronic NO 3 -supplementation in the absence of acute NO 3 -ingestion
In all previous studies examining the effect of chronic NO 3 -supplementation on the physiological responses to exercise, subjects have been instructed to consume their final dose of NO 3 -1-3 h prior to testing [e.g. 4, 5, 9, 12, 27, 29] . This experimental approach has been adopted to ensure a significant elevation in plasma [NO 
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